Scientists know that around 19 percent of those infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes Covid-19, contract a severe case of the disease. But it’s been difficult to predict which patients are most at risk of life-threatening illness.
Industries / Life Sciences
Messenger RNA (mRNA) is at the heart of the world’s most effective anti-corona vaccines and has also shown great promise in combatting cancer and other diseases. Now scientists at Germany’s Research Center Jülich, working with pharmaceutical company AstraZeneca, have discovered how it can be better administered under the skin.
He chose to locate in Jena, a small city in the eastern state of Thuringia, on account of its tradition of scientific innovation but also, he says, because “it’s a really nice place to live.”
The idea is to better connect medical research with medical treatment. The German Ministry of Education and Research (BMBF) has announced it will invest EUR 100 Million over the ten years to give specialist doctors, who are normally involved in daily practice, more opportunities to carry out research.
One hot start-up sector in Germany at the moment is products made from the cannabis derivative cannabidiol or CBD. Evidence suggests that CBD can alleviate disorders ranging from anxiety and insomnia to epilepsy without creating dependence or having intoxicating effects.
Coronavirus may have dominated the headlines last year, but Germany’s pharmaceutical companies were busy fighting disease on a number of fronts.
Pharmaceuticals colossus Bayer has partnered with German biotech company CureVac in the latter’s development of a vaccine to combat the coronavirus.
Finnish forest industry company UPM has begun construction a one-of-a-kind bio-refinery in the city of Leuna in the eastern German regional state of Saxony-Anhalt.
SKAN AG Group celebrated the groundbreaking ceremony for the next big expansion of its corporate site on the premises of the former lignite mine Görlitz/Hagenwerder in October 2020.
Medical products „Made in Germany“ are used worldwide. In the corona crisis, German medtech companies have proven that the industry is able to react very quickly to extraordinary situations and meet global requirements at short notice. The German government is strengthening this innovative power through targeted stimulus. Watch our video to learn more.